These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7915315)

  • 1. Is the sympathoinhibitory effect of rilmenidine mediated by alpha-2 adrenoceptors or imidazoline receptors?
    Urban R; Szabo B; Starke K
    J Pharmacol Exp Ther; 1994 Aug; 270(2):572-8. PubMed ID: 7915315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
    Bock C; Niederhoffer N; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors.
    Evans RG; Anderson WP
    Br J Pharmacol; 1995 Sep; 116(1):1557-70. PubMed ID: 8564219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of sympathoinhibition by imidazolines.
    Szabo B; Urban R
    Ann N Y Acad Sci; 1995 Jul; 763():552-65. PubMed ID: 7677373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine.
    Chan CK; Burke SL; Head GA
    J Hypertens; 2007 Jan; 25(1):147-55. PubMed ID: 17143186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B; Urban R
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of alpha 2-adrenoceptors in the cardiovascular effects of moxonidine.
    Urban R; Szabo B; Starke K
    Eur J Pharmacol; 1995 Aug; 282(1-3):19-28. PubMed ID: 7498275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathoinhibition by rilmenidine in conscious rabbits: involvement of alpha 2-adrenoceptors.
    Szabo B; Urban R; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):593-600. PubMed ID: 7907776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of imidazoline receptors in the baroreflex effects of rilmenidine in conscious rabbits.
    Head GA; Burke SL; Sannajust FJ
    J Hypertens; 2001 Sep; 19(9):1615-24. PubMed ID: 11564982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site and receptors involved in the sympathoinhibitory actions of rilmenidine.
    Head GA; Burke SL; Chan CK
    J Hypertens Suppl; 1998 Aug; 16(3):S7-12. PubMed ID: 9747904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rilmenidine on baroreflex control of renal sympathetic nerve activity.
    Sannajust F; Head GA
    J Hypertens Suppl; 1993 Dec; 11(5):S328-9. PubMed ID: 7908964
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of imidazoline receptors in the cardiovascular actions of moxonidine, rilmenidine and clonidine in conscious rabbits.
    Chan CK; Sannajust F; Head GA
    J Pharmacol Exp Ther; 1996 Feb; 276(2):411-20. PubMed ID: 8632304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rilmenidine-induced hypotension in conscious rabbits involves imidazoline-preferring receptors.
    Sannajust F; Head GA
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):42-50. PubMed ID: 7511734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanol counteraction of I1-imidazoline but not alpha-2 adrenergic receptor-mediated reduction in vascular resistance in conscious spontaneously hypertensive rats.
    El-Mas MM; Abdel-Rahman AA
    J Pharmacol Exp Ther; 1999 Feb; 288(2):455-62. PubMed ID: 9918545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No evidence for functional imidazoline receptors on locus coeruleus neurons.
    Szabo B; Fröhlich R; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):557-63. PubMed ID: 8740150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of peripheral presynaptic inhibition in the reduction of sympathetic tone by moxonidine, rilmenidine and UK 14304.
    Urban R; Szabo B; Starke K
    Eur J Pharmacol; 1995 Aug; 282(1-3):29-37. PubMed ID: 7498287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol selectively counteracts hypotension evoked by central I(1)-imidazoline but not alpha2-adrenergic receptor activation in spontaneously hypertensive rats.
    El-Mas MM; Abdel-Rahman AA
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):382-9. PubMed ID: 9733351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathoinhibitory action of rilmenidine in conscious sinoaortically denervated rats.
    Mayorov D; Chernobelski M; Medvedev O
    J Cardiovasc Pharmacol; 1993 Aug; 22(2):314-20. PubMed ID: 7692175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of the sympathoinhibition produced by the clonidine-like drugs rilmenidine and moxonidine.
    Szabo B; Bock C; Nordheim U; Niederhoffer N
    Ann N Y Acad Sci; 1999 Jun; 881():253-64. PubMed ID: 10415923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxonidine displays a presynaptic alpha-2-adrenoceptor-dependent synergistic sympathoinhibitory action at imidazoline-1 receptors.
    Schäfer U; Burgdorf C; Engelhardt A; Raasch W; Kurz T; Richardt G
    Ann N Y Acad Sci; 2003 Dec; 1009():265-9. PubMed ID: 15028597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.